Sino Biological invites you to the 2nd Annual AI-Powered Innovation in Protein and Antibody Therapeutics (AIPAT) Symposium, a premier gathering of leading minds dedicated to shaping the future of biopharma discovery.

This year’s symposium features deep dives into machine learning models, in silico screening, and bridging the crucial gap between computationally designed proteins and real-world clinical application.

Join us at Le Méridien Cambridge on October 2nd to connect with industry pioneers, spark new collaborations, and help drive the next generation of AI-driven therapeutics. Enjoy great talks and devoted times for networking including a rooftop cocktail reception!

Featured Speakers include:
-Dr. Diane Joseph-McCarthy – Executive Director, Bioengineering Technology & Entrepreneurship Center; Professor of the Practice, Biomedical Engineering & Chemistry, Boston University; AIMBE fellow (Opening Keynote)
-Dr. Abigail Lytton-Jean – Founding Scientific Director, NanoFIB, Koch Institute for Integrative Cancer Research at MIT (Scientific Keynote)
-Dr. Matthew Bakalar – Head of Innovation Science, Basecamp Research (Industry Keynote)
-Dr. Daniel Bedinger – Senior Manager, Field Application Science, Carterra
-Dr. Leo Wan – Founder and CEO, Ranomics
-Dr. Will Cao – Co-Founder & CEO, Pando Bioscience
-Devan Shah – Founder & CEO, RNAV8 Bio
-Allison Colhoart – Sr Principal Scientist of Drug Creation team, Seismic Therapeutic

Want to add your name to this list and win up to $2,000? We invite researchers to submit abstracts for oral presentations. Submissions should focus on advancements in AI-driven protein and antibody therapeutics. All participants will receive free registration. Submission Deadline: August 31, 2026

Awards:
1st Place – $2000
2nd Place – $1000
3rd Place – $500